Polycystic Kidney Diseases Clinical Trial
Official title:
Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
Pathological features of Autosomal Dominant Polycystic Kidney disease (ADPKD) include enlarged kidney volume, a higher frequency of digestive diverticulitis and abdominal wall hernias. Therefore, many nephrologists have concerns about the use of peritoneal dialysis (PD) in ADPKD patients. We aimed to analyze survival and technique failure in ADPKD patients treated with PD.
Pathological features of Autosomal Dominant Polycystic Kidney disease (ADPKD) include enlarged kidney volume, a higher frequency of digestive diverticulitis and abdominal wall hernias. Therefore, many nephrologists have concerns about the use of peritoneal dialysis (PD) in ADPKD patients. We aimed to analyze survival and technique failure in ADPKD patients treated with PD. We conducted two retrospective studies on patients starting dialysis between 2000 and 2010, and based on two French registries: The French Renal Epidemiology and Information Network (REIN) and The French Language Peritoneal Dialysis Registry (RDPLF). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04039061 -
ADPKD Patient Registry
|
||
| Enrolling by invitation |
NCT05215964 -
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
|
||
| Recruiting |
NCT01680250 -
Sirolimus for Massive Polycystic Liver
|
Phase 2/Phase 3 | |
| Completed |
NCT00286156 -
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06036992 -
Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
|
||
| Terminated |
NCT01009957 -
Everolimus on CKD Progression in ADPKD Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Completed |
NCT02739750 -
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
|
||
| Completed |
NCT03889392 -
Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD
|
||
| Recruiting |
NCT03726463 -
Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD
|
||
| Completed |
NCT03423810 -
Assessing a Dose‐Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
|
Early Phase 1 |